AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 278 filers reported holding AVANOS MED INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $142 | -10.7% | 7,053 | +13.3% | 0.00% | – |
| Q2 2023 | $159 | -14.1% | 6,225 | 0.0% | 0.00% | – |
| Q1 2023 | $185 | +10.1% | 6,225 | 0.0% | 0.00% | – |
| Q4 2022 | $168 | -99.9% | 6,225 | +10.2% | 0.00% | – |
| Q3 2022 | $123,000 | -90.3% | 5,650 | -85.1% | 0.00% | -100.0% |
| Q1 2022 | $1,266,000 | +2844.2% | 37,818 | +2769.3% | 0.00% | – |
| Q3 2020 | $43,000 | -99.8% | 1,318 | -99.8% | 0.00% | -100.0% |
| Q3 2019 | $22,197,000 | -17.3% | 592,564 | -3.8% | 0.04% | -18.2% |
| Q2 2019 | $26,856,000 | -7.6% | 615,831 | -9.6% | 0.04% | -8.3% |
| Q1 2019 | $29,060,000 | +20.9% | 680,885 | +26.9% | 0.05% | +9.1% |
| Q4 2018 | $24,027,000 | -21.7% | 536,445 | +19.8% | 0.04% | -12.0% |
| Q3 2018 | $30,682,000 | – | 447,920 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
| RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
| Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
| Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
| Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
| Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
| HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
| Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
| S.A. Mason LLC | 6,527 | $299,000 | 0.25% |